Comments

Dynavax Technologies Stock Price, Quotes and Forecasts

Q: What sector and industry does Dynavax Technologies (DVAX) operate in?

Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

DVAXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$10.27

-0.13-1.25%

At close: -

$10.19

-0.08-0.78%

After Hours: 4:03 PM EDT

Dynavax Technologies (DVAX) Forecast

News Earnings Dynavax Technologies (DVAX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Dynavax Technologies Stock Price, Quotes and Forecasts | NASDAQ:DVAX | Benzinga

Explore Dynavax Technologies stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DVAX.

Open	$10.27
Close	$10.27
Volume / Avg.	1.12M / 2.29M
Day Range	$10.21 - $10.42
52 Wk Range	9.22 - 14.63
Market Cap	$1.22B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	19.58%
Days to Cover	8.68

Recent News

Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation

FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns.

Vandana Singh

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand.

Vandana Singh

This Columbus McKinnon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$10.27
Close	$10.27
Volume / Avg.	1.12M / 2.29M
Day Range	$10.21 - $10.42
52 Wk Range	9.22 - 14.63
Market Cap	$1.22B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	19.58%
Days to Cover	8.68

About Dynavax Technologies Corp.

Sector

Health Care

Industry

Biotechnology

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the powe...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Dynavax Technologies (DVAX) stock?

You can purchase shares of Dynavax Technologies (NASDAQ:DVAX) through any online brokerage.

View our list of the best stock brokerages

Who are Dynavax Technologies (DVAX) competitors?

Other companies in Dynavax Technologies’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX) and Arcutis Biotherapeutics (NASDAQ:ARQT).

What is the forecast, or price target, for Dynavax Technologies (DVAX) stock?

Dynavax Technologies has a consensus price target of $25.20.

What is the current price for Dynavax Technologies (DVAX)?

The stock price for Dynavax Technologies (NASDAQ: DVAX) is $10.19 last updated June 13, 2025 at 4:03 PM EDT.

Does Dynavax Technologies (DVAX) pay a dividend?

There are no upcoming dividends for Dynavax Technologies.

When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?

Dynavax Technologies’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is Dynavax Technologies (DVAX) going to split?

There is no upcoming split for Dynavax Technologies.

What sector and industry does Dynavax Technologies (DVAX) operate in?

Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.